<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21693">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01873612</url>
  </required_header>
  <id_info>
    <org_study_id>PropDexHVRVolunteers</org_study_id>
    <nct_id>NCT01873612</nct_id>
  </id_info>
  <brief_title>Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim with this project is to investigate the effect of dexmedetomidine on control
      of breathing in healthy volunteers and to compare it with propofol at the same degree of
      sedation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      15 volunteers will be investigated for their hypoxic and hypercapnic ventilatory response
      during sedation with dexmedetomidine and propofol in a randomized cross-over study.

      6 volunteers will be investigated for their repeated response to hypoxia and hypercapnia in
      order to validate the method.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Hypoxic ventilatory response</measure>
    <time_frame>One day for each drug; before,during and after sedation with dexmeditomidine or propofol</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Acute hypoxic ventilatory response,i.e. the ventilatory response to acute hypoxia measured as change in minute ventilation over change in peripheral oxygen saturation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hypercapnic ventilatory response</measure>
    <time_frame>One day for each drug; Before, during and after sedation with dexmedetomidine or propofol</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The acute ventilatory response to hypercapnia, i.e. change in minute ventilation over change in end-tidal carbon dioxide</description>
  </secondary_outcome>
  <other_outcome>
    <measure>upper airway obstruction</measure>
    <time_frame>One day for each drug: Before, during and after sedation with dexmedetomidine or propofol</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Objective signs of upper airway obstruction, e.g. Interruption of airflow at the same time as breathing movements of the thoracic wall, paradoxal breathing, increased airway resistance</description>
  </other_outcome>
  <other_outcome>
    <measure>Plasma concentration</measure>
    <time_frame>One day for each drug; At target sedation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Plasma concentration of dexmedetomidine or propofol</description>
  </other_outcome>
  <other_outcome>
    <measure>Sedation level</measure>
    <time_frame>One day; During the whole experimental procedure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Sedation level will be measured as Richmond Agitation Sedation Scale(RASS) the observer's assessment of alertness/sedation scale (OAA/S)</description>
  </other_outcome>
  <other_outcome>
    <measure>Bispectral index</measure>
    <time_frame>One day; During the whole experimental procedure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Bispectral index (BIS) gives a number between 0-100</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Hypoxia</condition>
  <condition>Anesthetics</condition>
  <condition>Conscious Sedation</condition>
  <condition>Hypercapnia</condition>
  <arm_group>
    <arm_group_label>Sedation with dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation with dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedation with propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation with propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypoxic ventilatory response</intervention_name>
    <arm_group_label>Sedation with dexmedetomidine</arm_group_label>
    <arm_group_label>Sedation with propofol</arm_group_label>
    <other_name>HVR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypercapnic ventilatory response</intervention_name>
    <arm_group_label>Sedation with dexmedetomidine</arm_group_label>
    <arm_group_label>Sedation with propofol</arm_group_label>
    <other_name>HCVR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male

          2. Age 18-40

          3. American Society of AnesthesiologistÂ´s classification (ASA) 1, i.e. healthy

          4. No medication

          5. No allergies

          6. Non-smoker/no snuff, i.e. no nicotine intake

          7. Normal weight, BMI &lt;26

        Exclusion Criteria:

        Snoring
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malin Jonsson Fagerlund, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital and Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Malin Jonsson Fagerlund, MD, PhD</last_name>
    <email>malin.jonsson.fagerlund@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology, Surgical Sciences and Intensive Care Medicine, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>SE-17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malin Jonsson Fagerlund, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Malin Jonsson Fagerlund, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 2, 2014</lastchanged_date>
  <firstreceived_date>May 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Malin Jonsson Fagerlund</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Propofol</keyword>
  <keyword>Hypoxic ventilatory response</keyword>
  <keyword>Hypercapnic ventilatory response</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypercapnia</mesh_term>
    <mesh_term>Anoxia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
